• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢型谷氨酸 mGlu2 受体是致幻 5-HT2A 受体激动剂引起的药理学和行为学效应所必需的。

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

机构信息

Department of Psychiatry, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1229, New York, NY 10029, United States.

出版信息

Neurosci Lett. 2011 Apr 15;493(3):76-9. doi: 10.1016/j.neulet.2011.01.046. Epub 2011 Jan 27.

DOI:10.1016/j.neulet.2011.01.046
PMID:21276828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3064746/
Abstract

Hallucinogenic drugs, including mescaline, psilocybin and lysergic acid diethylamide (LSD), act at serotonin 5-HT2A receptors (5-HT2ARs). Metabotropic glutamate receptor 2/3 (mGluR2/3) ligands show efficacy in modulating the responses induced by activation of 5-HT2ARs. The formation of a 5-HT2AR-mGluR2 complex suggests a functional interaction that affects the hallucinogen-regulated cellular signaling pathways. Here, we tested the cellular and behavioral effects of hallucinogenic 5-HT2AR agonists in mGluR2 knockout (mGluR2-KO) mice. Mice were intraperitoneally injected with the hallucinogens DOI (2 mg/kg) and LSD (0.24 mg/kg), or vehicle. Head-twitch behavioral response, expression of c-fos, which is induced by all 5-HT2AR agonists, and expression of egr-2, which is hallucinogen-specific, were determined in wild type and mGluR2-KO mice. [(3)H]Ketanserin binding displacement curves by DOI were performed in mouse frontal cortex membrane preparations. Head twitch behavior was abolished in mGluR2-KO mice. The high-affinity binding site of DOI was undetected in mGluR2-KO mice. The hallucinogen DOI induced c-fos in both wild type and mGluR2-KO mice. However, the induction of egr-2 by DOI was eliminated in mGlu2-KO mice. These findings suggest that the 5-HT2AR-mGluR2 complex is necessary for the neuropsychological responses induced by hallucinogens.

摘要

致幻药物,包括三甲氧苯乙胺、裸盖菇素和麦角酸二乙基酰胺(LSD),作用于血清素 5-HT2A 受体(5-HT2AR)。代谢型谷氨酸受体 2/3(mGluR2/3)配体在调节 5-HT2AR 激活诱导的反应方面显示出疗效。5-HT2AR-mGluR2 复合物的形成表明存在一种功能相互作用,影响致幻剂调节的细胞信号通路。在这里,我们测试了致幻 5-HT2AR 激动剂在 mGluR2 敲除(mGluR2-KO)小鼠中的细胞和行为效应。将致幻剂 DOI(2mg/kg)和 LSD(0.24mg/kg)或载体通过腹膜内注射到小鼠中。在野生型和 mGluR2-KO 小鼠中测定了摇头行为反应、所有 5-HT2AR 激动剂诱导的 c-fos 表达和致幻剂特异性的 egr-2 表达。在小鼠额叶皮质膜制剂中进行了由 DOI 引起的 [(3)H] 酮色林结合位移曲线。摇头行为在 mGluR2-KO 小鼠中被消除。在 mGluR2-KO 小鼠中未检测到高亲和力结合位点的 DOI。致幻剂 DOI 诱导了野生型和 mGluR2-KO 小鼠中的 c-fos。然而,DOI 诱导的 egr-2 在 mGlu2-KO 小鼠中被消除。这些发现表明 5-HT2AR-mGluR2 复合物是致幻剂诱导的神经心理反应所必需的。

相似文献

1
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.代谢型谷氨酸 mGlu2 受体是致幻 5-HT2A 受体激动剂引起的药理学和行为学效应所必需的。
Neurosci Lett. 2011 Apr 15;493(3):76-9. doi: 10.1016/j.neulet.2011.01.046. Epub 2011 Jan 27.
2
Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.慢性给予 LY341495 可降低小鼠 5-HT(2A) 受体结合和 LSD 的致幻作用。
Neurosci Lett. 2013 Mar 1;536:69-73. doi: 10.1016/j.neulet.2012.12.053. Epub 2013 Jan 16.
3
Role of mGlu2 in the 5-HT receptor-dependent antipsychotic activity of clozapine in mice.mGlu2 在氯氮平 5-HT 受体依赖性抗精神病活性中的作用。
Psychopharmacology (Berl). 2018 Nov;235(11):3149-3165. doi: 10.1007/s00213-018-5015-4. Epub 2018 Sep 12.
4
Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.慢性给予代谢型谷氨酸 2/3 受体激动剂可减弱对苯乙胺类致幻剂的行为反应。
Psychopharmacology (Berl). 2019 Feb;236(2):821-830. doi: 10.1007/s00213-018-5118-y. Epub 2018 Nov 17.
5
N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.N-乙酰半胱氨酸调节致幻性5-羟色胺(5-HT)2A受体激动剂介导的反应:行为学、分子学和电生理学研究
Neuropharmacology. 2014 Jun;81:215-23. doi: 10.1016/j.neuropharm.2014.02.006. Epub 2014 Feb 15.
6
Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.致幻 5-HT2AR 激动剂 LSD 和 DOI 增强多巴胺 D2R 原聚体识别和 D2-5-HT2A 异源受体复合物的信号转导。
Biochem Biophys Res Commun. 2014 Jan 3;443(1):278-84. doi: 10.1016/j.bbrc.2013.11.104. Epub 2013 Dec 2.
7
Identification of a serotonin/glutamate receptor complex implicated in psychosis.与精神病相关的5-羟色胺/谷氨酸受体复合物的鉴定。
Nature. 2008 Mar 6;452(7183):93-7. doi: 10.1038/nature06612. Epub 2008 Feb 24.
8
Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HTR-Mediated G Signaling Pathway.激动型代谢型谷氨酸受体 2 激动剂/反向激动剂对大麻诱导的摇头反应的调制与 5-羟色胺能介导的 G 信号通路有关。
Neurochem Res. 2024 Mar;49(3):636-648. doi: 10.1007/s11064-023-04055-y. Epub 2023 Nov 21.
9
Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.转录组指纹图谱可区分致幻和非致幻5-羟色胺2A受体激动剂对小鼠体感皮层的作用。
J Neurosci. 2003 Oct 1;23(26):8836-43. doi: 10.1523/JNEUROSCI.23-26-08836.2003.
10
Interclass GPCR heteromerization affects localization and trafficking.类间 G 蛋白偶联受体异源二聚体影响定位和转运。
Sci Signal. 2020 Oct 20;13(654):eaaw3122. doi: 10.1126/scisignal.aaw3122.

引用本文的文献

1
Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.在雄性大鼠反复暴露于低强度爆炸后,其大脑前皮质中血清素5-HT2A受体的表达长期减少。
Front Neurol. 2025 Jun 25;16:1594335. doi: 10.3389/fneur.2025.1594335. eCollection 2025.
2
Translation-independent association of mRNAs that encode protomers of the 5-HT-mGlu2 receptor complex.编码5-羟色胺-mGlu2受体复合物亚基的mRNA的非翻译依赖性关联。
J Biol Chem. 2025 Jun 26;301(8):110427. doi: 10.1016/j.jbc.2025.110427.
3
The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity.

本文引用的文献

1
Group II metabotropic glutamate receptors and schizophrenia.第二组代谢型谷氨酸受体与精神分裂症。
Cell Mol Life Sci. 2009 Dec;66(23):3777-85. doi: 10.1007/s00018-009-0130-3. Epub 2009 Aug 26.
2
Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration.GABAB 和 mGlu1a 受体之间的串扰揭示了 GPCR 信号整合的新见解。
EMBO J. 2009 Aug 5;28(15):2195-208. doi: 10.1038/emboj.2009.177. Epub 2009 Jul 9.
3
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.
N,N-二甲基色胺的演变:从代谢途径到脑连接性
Psychopharmacology (Berl). 2025 Apr 11. doi: 10.1007/s00213-025-06777-z.
4
Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons.血清素能致幻剂可快速调节培养皮层神经元中诱发的谷氨酸释放。
J Neurochem. 2025 Mar;169(3):e70020. doi: 10.1111/jnc.70020.
5
Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.用于治疗强迫症的迷幻剂:疗效及潜在机制
Int J Neuropsychopharmacol. 2024 Dec 1;27(12). doi: 10.1093/ijnp/pyae057.
6
Human pluripotent stem cells as a translational toolkit in psychedelic research .人类多能干细胞作为迷幻剂研究中的一种转化工具
iScience. 2024 Mar 28;27(5):109631. doi: 10.1016/j.isci.2024.109631. eCollection 2024 May 17.
7
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.创伤后应激障碍治疗的迷幻未来。
Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147.
8
Psychedelic-like Activity of Norpsilocin Analogues.具有迷幻样活性的诺匹克隆类似物。
ACS Chem Neurosci. 2024 Jan 17;15(2):315-327. doi: 10.1021/acschemneuro.3c00610. Epub 2024 Jan 8.
9
Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.致幻蘑菇诱导的默认模式网络连接减少在酒精依赖大鼠中被削弱。
Transl Psychiatry. 2023 Dec 14;13(1):392. doi: 10.1038/s41398-023-02690-1.
10
The bodily self from psychosis to psychedelics.从精神病学到迷幻剂的身体自我。
Sci Rep. 2023 Dec 1;13(1):21209. doi: 10.1038/s41598-023-47600-z.
G 蛋白偶联受体异源二聚化:对药理学和功能的贡献。
Br J Pharmacol. 2009 Sep;158(1):5-14. doi: 10.1111/j.1476-5381.2009.00169.x. Epub 2009 Mar 20.
4
Agonist-trafficking and hallucinogens.激动剂转运与致幻剂
Curr Med Chem. 2009;16(8):1017-27. doi: 10.2174/092986709787581851.
5
Psychedelics and schizophrenia.迷幻药与精神分裂症
Trends Neurosci. 2009 Apr;32(4):225-32. doi: 10.1016/j.tins.2008.12.005. Epub 2009 Mar 5.
6
Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices.通过在皮质脑片中诱导紊乱的神经元网络活动来在体外模拟“精神病”。
Psychopharmacology (Berl). 2009 Nov;206(4):575-85. doi: 10.1007/s00213-009-1484-9. Epub 2009 Feb 25.
7
Serotonin research: contributions to understanding psychoses.血清素研究:对理解精神病的贡献。
Trends Pharmacol Sci. 2008 Sep;29(9):445-53. doi: 10.1016/j.tips.2008.06.006.
8
Promise of mGluR2/3 activators in psychiatry.代谢型谷氨酸受体2/3激活剂在精神病学领域的前景。
Neuropsychopharmacology. 2009 Jan;34(1):248-9. doi: 10.1038/npp.2008.156.
9
On the fitting of binding data when receptor dimerization is suspected.当怀疑存在受体二聚化时结合数据的拟合
Br J Pharmacol. 2008 Sep;155(1):17-23. doi: 10.1038/bjp.2008.234. Epub 2008 Jun 9.
10
Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).代谢型谷氨酸(mGlu)2而非mGlu3受体在mGlu2/3受体激动剂(-)-(1R,4S,5S,6S)-4-氨基-2-磺酰基双环[3.1.0]己烷-4,6-二羧酸(LY404039)临床前抗精神病药理学中的作用证据。
J Pharmacol Exp Ther. 2008 Jul;326(1):209-17. doi: 10.1124/jpet.108.136861. Epub 2008 Apr 18.